Robin Carr, Myricx Bio 🇬🇧 | New ADC Payloads, London Biotech Startups | E38
We jet off to Central London to meet Robin Carr, CEO of Myricx Bio, a...
Why ADCs and Radiopharmaceuticals Are Big Pharma’s New Obsession
Antibody-drug conjugates (ADCs) and radiopharmaceuticals have moved from the fringes of biotech buzzwords into the...
Never miss a new episode đź’Ś
Trusted by 1000+ professionals from top companies like Argenx, BioNTech, or Genmab. No spam, no noise.
Watch & Subscribe
